<code id='ECEC35152F'></code><style id='ECEC35152F'></style>
    • <acronym id='ECEC35152F'></acronym>
      <center id='ECEC35152F'><center id='ECEC35152F'><tfoot id='ECEC35152F'></tfoot></center><abbr id='ECEC35152F'><dir id='ECEC35152F'><tfoot id='ECEC35152F'></tfoot><noframes id='ECEC35152F'>

    • <optgroup id='ECEC35152F'><strike id='ECEC35152F'><sup id='ECEC35152F'></sup></strike><code id='ECEC35152F'></code></optgroup>
        1. <b id='ECEC35152F'><label id='ECEC35152F'><select id='ECEC35152F'><dt id='ECEC35152F'><span id='ECEC35152F'></span></dt></select></label></b><u id='ECEC35152F'></u>
          <i id='ECEC35152F'><strike id='ECEC35152F'><tt id='ECEC35152F'><pre id='ECEC35152F'></pre></tt></strike></i>

          focus

          focus

          author:comprehensive    Page View:9

          Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET.

          Relive this year’s J.P. Morgan Healthcare Conference with the STAT reporters who attended. Get a full rundown of the deals, data, and scuttlebutt and come away with the ideas and water-cooler chatter you need for the year ahead.

          advertisement

          Sponsor introduction

          • John Arena, SVP, enterprise strategy & solutions, Cencora

          Featured speakers

          • Tara Bannow, hospitals and insurance reporter, STAT
          • Damian Garde, national biotech reporter, STAT
          • Matthew Herper, senior writer, medicine; editorial director of events, STAT
          • Allison DeAngelis, biotech startups and venture capital reporter, STAT (moderator)

          Sponsored By

          Cencora

          explore

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          Anavex keeps shifting the goalposts in its clinical trials
          Anavex keeps shifting the goalposts in its clinical trials

          MollyFerguson/STATAnavexLifeSciencesisinatoughspot.Theserialdissemblerofclinicaltrialresultsmightbef

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          Drastic changes should bring profitability, startup health insurers say

          AdobeStartupinsurersOscarHealth,BrightHealth,andCloverHealthhavehemorrhagedmoneysincegoingpublicwith